DASATINIB DAILY DOSE OPTIMIZATION BASED ON RESIDUAL DRUG LEVELS RESULTED IN REDUCED RISK OF PLEURAL EFFUSIONS AND HIGH MOLECULAR RESPONSE RATES: FINAL RESULTS OF THE RANDOMIZED OPTIM DASATINIB TRIAL.P. Rousselot,L. Mollica, A. Guerci-Bresler,F. E. Nicolini,G. Etienne,L. Legros,A. Charbonnier, V. Coiteux, C. Dartigeas,M. Escoffre-Barbe,L. Roy, P. Cony-Makhoul,V. Dubruille,M. Gardembas,C. Berthou,F. Huguet,B. Deau, E. Jourdan, L. Fouillard,S. Malak,D. Rea, L. Busque,F. Guilhot,M. Molimard,J. Guilhot,J. M. Cayuela, S. Bouchet,F. X. MahonHAEMATOLOGICA（2014）引用 1|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
